51 results
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
14 Feb 24
Regulation FD Disclosure
7:00am
pandemic; risks associated with the increased scrutiny related to environmental, social and governance (ESG) m atters, its ability to commercialize
8-K
EX-10.1
BTAI
BioXcel Therapeutics Inc
8 Feb 24
Other Events
4:53pm
Adverse Change; provided, that for purposes of this Section 7.04(b), the impacts of the COVID-19 pandemic on the business, operations or financial
8-K
EX-99.1
BTAI
BioXcel Therapeutics Inc
14 Nov 23
Results of Operations and Financial Condition
12:00am
-attacks, if any; impacts from the COVID-19 pandemic; risks associated with the increased scrutiny relating to environmental, social and governance (ESG
8-K
EX-99.2
e3872onrd
10 Oct 23
Regulation FD Disclosure
7:06am
8-K
EX-99.1
mpunckwrcz vwa7
10 Oct 23
Regulation FD Disclosure
7:06am
8-K
qzjy6mzb
4 Oct 23
Regulation FD Disclosure
7:05am
8-K
EX-99.1
0jy krrjk5lolr7
14 Aug 23
BioXcel Therapeutics Reports Second Quarter 2023 Financial Results and Announces Strategic Reprioritization
7:20am
8-K
EX-99.1
eijftaw3essqmx6tpm
8 May 23
BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
8:30am
8-K
7agy5l3
20 Apr 23
Other Events
7:00am
8-K
EX-99.1
i5ts1wp3bs9jadh5z
10 Nov 22
BioXcel Therapeutics Reports Third Quarter 2022 Financial Results and Recent Operational Highlights
7:15am
8-K
aqoavotp
12 Sep 22
Other Events
7:00am
8-K
EX-99.1
bxn b1qeg
12 Sep 22
Other Events
7:00am